Inhibition of cellular immune reactions by zymosan.
Mice treated intraperitoneally with zymosan showed a strong inhibition of the DTHR (delayed-type hypersensitivity reaction) against sheep erythrocytes (SE), ovalbumin (OA), and alloantigen. Furthermore, the rejection time of skin transplants was nearly doubled while antibody formation against SE was significantly enhanced. When a DTHR against OA and an antibody formation against SE were induced at the same time in the same animals, than the suppressive and stimulating effects cancelled each other. These results are discussed with regard to the sensitivity of lymphocyte subpopulations, which may be different if exposed to phagocytosis-induced oxygen radicals.
Eckert
R
R
Department of Medical Immunology, Medical School (Charité), Humboldt University Berlin, Germany.
Garn
H
H
Volk
H D
HD
von Baehr
R
R
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D006084:Graft Rejection; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects*; D051379:Mice; D008815:Mice, Inbred Strains; D010047:Ovalbumin / Q000276:immunology; D016038:Skin Transplantation / Q000276:immunology; D015054:Zymosan / Q000494:pharmacology*
D010047:Ovalbumin; D015054:Zymosan